These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 16114043)
1. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Djojosubroto MW; Chin AC; Go N; Schaetzlein S; Manns MP; Gryaznov S; Harley CB; Rudolph KL Hepatology; 2005 Nov; 42(5):1127-36. PubMed ID: 16114043 [TBL] [Abstract][Full Text] [Related]
2. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition. Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257 [TBL] [Abstract][Full Text] [Related]
3. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619 [TBL] [Abstract][Full Text] [Related]
4. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells. Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117 [TBL] [Abstract][Full Text] [Related]
5. Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer. Gellert GC; Dikmen ZG; Wright WE; Gryaznov S; Shay JW Breast Cancer Res Treat; 2006 Mar; 96(1):73-81. PubMed ID: 16319992 [TBL] [Abstract][Full Text] [Related]
6. In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; Dogan P; Wright WE; Shay JW Cancer Res; 2005 Sep; 65(17):7866-73. PubMed ID: 16140956 [TBL] [Abstract][Full Text] [Related]
12. Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Lin CP; Liu JD; Chow JM; Liu CR; Liu HE Anticancer Drugs; 2007 Feb; 18(2):161-70. PubMed ID: 17159602 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Ozawa T; Gryaznov SM; Hu LJ; Pongracz K; Santos RA; Bollen AW; Lamborn KR; Deen DF Neuro Oncol; 2004 Jul; 6(3):218-26. PubMed ID: 15279714 [TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors. Herbert BS; Pongracz K; Shay JW; Gryaznov SM Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790 [TBL] [Abstract][Full Text] [Related]
15. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. Kelland LR Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745 [TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma. Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166 [TBL] [Abstract][Full Text] [Related]
18. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo. Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987 [TBL] [Abstract][Full Text] [Related]
19. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Zhang RG; Zhang RP; Wang XW; Xie H Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411 [TBL] [Abstract][Full Text] [Related]
20. Telomeres and telomerase: a dual role in hepatocarcinogenesis. Satyanarayana A; Manns MP; Rudolph KL Hepatology; 2004 Aug; 40(2):276-83. PubMed ID: 15368430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]